Search

everythinglearnresearchcommunity

for

Search:↓

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Certain compounds from Kushtakudori ennai may help treat hair loss.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

VEGF and its receptor might cause hair loss.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

PCOS can be treated with Ayurvedic therapies that balance doshas and improve digestion.

Psychological stress and personal history are significant factors in hair loss.

The free androgen index varies among women with different types of PCOS.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Systematic reviews on platelet-rich plasma therapy for hair loss have many quality issues.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

The conclusion is that there's a need for a new conference to establish stricter guidelines for diagnosing Polycystic Ovary Syndrome (PCOS).

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Finasteride may improve prostate cancer treatment outcomes.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Platelet-rich plasma therapy shows promise in treating hair loss caused by androgenic alopecia.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.